JW Holdings Corporation

KSE 096760.KS

JW Holdings Corporation Return on Equity (ROE) for the year ending December 31, 2023: 15.35%

JW Holdings Corporation Return on Equity (ROE) is 15.35% for the year ending December 31, 2023, a -64.67% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

JW Holdings Corporation Return on Equity (ROE) for the year ending December 31, 2022 was 43.44%, a 813.46% change year over year.
JW Holdings Corporation Return on Equity (ROE) for the year ending December 31, 2021 was 4.76%, a 53.41% change year over year.
JW Holdings Corporation Return on Equity (ROE) for the year ending December 31, 2020 was 3.10%, a 114.65% change year over year.
JW Holdings Corporation Return on Equity (ROE) for the year ending December 31, 2019 was -21.15%, a -266.01% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

KSE: 096760.KS

JW Holdings Corporation

CEO	Mr. Kyung-Ha Lee
IPO Date	May 5, 2006
Location	South Korea
Headquarters	2477, Nambusunhwan-ro
Employees	136
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies Medical Instruments

Description

JW Holdings Corporation, together with its subsidiaries, manufactures and sells medicines and medical devices in South Korea and internationally. It offers ETC products, consumer healthcare OTC products, and IV solutions machinery systems. The company also exports its products. JW Holdings Corporation was founded in 1945 and is based in Seoul, South Korea.

Key trends

Past 5 years